Join BU Nutrition as a Senior Launch Manager and play a pivotal role in bringing innovative nutrition products to market globally. In this role, you will drive end-to-end launch preparation and execution across regions and functions, ensuring speed, quality, and commercial readiness. You will operate at the intersection of development, supply chain, regulatory, and commercial functions, enabling disciplined launches in a complex global matrix. If you are passionate about accelerating time-to-market and orchestrating successful product launches at scale, this is your opportunity to make a measurable impact.
Lead cross-functional and multi-regional launch teams from launch preparation kickoff through first sales
Drive global launch preparation within development projects and market rollouts
Plan, track, and optimize launch timelines, milestones, and readiness activities
Identify, assess, and mitigate launch risks; escalate challenges on the critical path to governance bodies
Ensure fact-based status reporting and decision-making in launch and governance forums
Oversee launch KPIs, performance tracking, and post-launch reviews
Contribute to the continuous improvement of launch processes, tools, templates, and training
Actively collaborate with regional and global stakeholders to prioritize key market launches
Master’s degree in science, pharmacy, medicine, engineering, or health economics
Minimum 7 years of professional experience, including at least 5 years in launch, project, product, or supply chain management
Experience in pharmaceuticals, medical devices, combination products, or clinical nutrition
Strong understanding of commercialization, supply chain readiness, and market access considerations
Proven ability to lead cross-functional teams in a global matrix without formal authority
Fluency in English; German or Chinese is an asset
Proficient in MS Office 365, MS Project, Visio, and SharePoint
Strong analytical, organizational, and stakeholder management skills
Resilient, execution focused, and comfortable operating under time pressure
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint
